BTG945 drug significantly reduced tumours in seven out of 15 women Researchers will today unveil the preliminary findings at a Chicago conference Unlike most gruelling cancer therapies, there are very few side effects Thousands of women with ovarian cancer could be helped by the most promising new drug in a decade, British scientists claim. The...
Category: <span>Cancer</span>
Post
Prostate cancer treatment ‘could help more patients’
Image captionHormone therapy stops more testosterone from reaching the prostate gland One of the largest clinical trials for prostate cancer has given “powerful results”, say UK researchers. A drug for treating prostate cancer that has spread was found to save lives when offered earlier, a study found. The trial looked at abiraterone as an additional...
Post
Promising cancer treatment targets rare genetic flaw
An experimental cancer medicine called larotrectinib has shown promise treating a diverse range of cancers in people young and old, researchers said at a major cancer conference in the United States. The treatment targets a genetic abnormality which is often found in rare cancers—including salivary gland cancer, juvenile breast cancer, and a soft tissue cancer known as infantile fibrosarcoma—which are...
Post
An initial step toward blood tests for early detection of cancer
In a study of 124 patients with advanced breast, lung, and prostate cancers, a new, high-intensity genomic sequencing approach detected circulating tumor DNA at a high rate. In 89 percent of patients, at least one genetic change detected in the tumor was also detected in the blood. Overall, 627 (73 percent) genetic changes found...
Post
Two Combination Therapies Shrink Melanoma Brain Metastases in More Than Half of Patients
CHICAGO – High response rates to a pair of combination therapies point to potentially new options for a group of metastatic melanoma patients who have been largely left out of recent treatment progress – those whose disease has spread to the brain. A combination regimen of two immunotherapies and another of two targeted therapies each...
Post
Blocking cancer-specific mutations in leukemia and brain tumors
Candidate drug BAY1436032 (yellow) binds to the mutated enzyme IDH1. The substitution of a single amino acid in a metabolic enzyme can be the cause of various types of cancer. Scientists from the German Cancer Research Center and Heidelberg University Hospital, collaborating with Bayer AG, have now been able to develop a candidate for...
Post
Cold virus, stem cells tested to destroy deadly brain cancer
Killer T cells surround a cancer cell. A first-of-a-kind neural stem cell therapy that works with a common cold virus to seek out and attack a lethal and aggressive brain cancer is being tested at Northwestern Medicine in a Phase I clinical trial for patients newly diagnosed with malignant glioma. The novel drug to...
Post
Chemical array draws out malignant cells to guide individualized cancer treatment
A chemical array screens for malignant melanoma cell types. Each dot contains a different combination of protein segments derived from the tumor environment. Melanoma is a particularly difficult cancer to treat once it has metastasized, spreading throughout the body. University of Illinois researchers are using chemistry to find the deadly, elusive malignant cells within...
Post
Researchers Discover The Proteins Responsible For Cancer Metastasis And How To Control Them
Researchers Discover The Proteins Responsible For Cancer Metastasis And How To Control Them Cancer treatments do not always produce positive results despite advanced treatments and procedures designed to fight off the disease. Even with patients previously cleared of the disease, things could suddenly turn upside down when the tumors come back and quickly spread to other parts of the...
Post
How a bizarre skull cap could help to zap deadly brain cancer: Electrode therapy increases survival rate by 13%
A skull cap that fires electrical currents into the brain to kill cancer cells is being used to treat one of the most deadly forms of the disease. Patients with glioblastoma, a type of brain cancer that affects about 4,000 people in the UK every year, has an estimated survival rate of 12 to 18...